CS logo
small CS logo
National Hospital Organization Kinki-Chuo Chest Medical Center

Sakai Shi, Japan
Hospital in Sakai
1180 Nagasonecho, Kita Ward, Sakai, Osaka 591-8555

About National Hospital Organization Kinki-Chuo Chest Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
12
Hoffmann-La Roche
11
Chugai Pharmaceutical
2
Galapagos NV
2
Merck Sharp & Dohme LLC
2
Pfizer
2
Actelion
1
Amgen
1
Japan Clinical Oncology Group
1
North East Japan Study Group
1
Osaka University
1
Total Rows: 15

Clinical Trials at National Hospital Organization Kinki-Chuo Chest Medical Center


During the past decade, National Hospital Organization Kinki-Chuo Chest Medical Center conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 13 clinical trials were completed, i.e. on average, 40.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44333333557755220000112244221133Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)
2003-07-01
2012-02-01
Completed
200
Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)
2005-06-01
Completed
172
BUILD 3: Bosentan Use in Interstitial Lung Disease
2007-02-01
2010-07-01
Completed
616
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
2009-08-14
2017-03-16
Completed
345
ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
2011-06-16
2015-09-14
Completed
878
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
2012-06-06
2021-02-01
Completed
752
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,081
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
2013-10-13
2017-11-06
Completed
505

Rows per page:

1–40 of 40

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "National Hospital Organization Kinki-Chuo Chest Medical Center" #1 sponsor was "Boehringer Ingelheim" with 12 trials, followed by "Hoffmann-La Roche" with 11 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Merck Sharp & Dohme LLC" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kinki-Chuo Chest Medical Center" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Ministry of Health, Labour and Welfare, Japan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 12Boehringer Ingelheim: 12Hoffmann-La Roche: 11Hoffmann-La Roche: 11Chugai Pharmaceutical: 2Chugai Pharmaceutical: 2Galapagos NV: 2Galapagos NV: 2Merck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2Pfizer: 2Pfizer: 2Actelion: 1Actelion: 1Amgen: 1Amgen: 1Japan Clinical OncologyGroup: 1Japan Clinical OncologyGroup: 1North East Japan Study Group: 1North East Japan Study Group: 1

Created with Highcharts 11.1.0Top CollaboratorsJapan Lung Cancer Society: 2Japan Lung Cancer Society: 2Atea Pharmaceuticals, Inc.: 1Atea Pharmaceuticals, Inc.: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Ministry of Health,Labour and Welfare,Japan: 1Ministry of Health,Labour and Welfare,Japan: 1

Clinical Trials Conditions at National Hospital Organization Kinki-Chuo Chest Medical Center


According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kinki-Chuo Chest Medical Center" are "Idiopathic Pulmonary Fibrosis" (11 trials), "Lung Diseases, Interstitial" (4 trials), "Non-Small Cell Lung Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "ALK-positive Non-small-cell Lung Cancer" (1 trials). Many other conditions were trialed in "National Hospital Organization Kinki-Chuo Chest Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at National Hospital Organization Kinki-Chuo Chest Medical Center


Most popular intervention types in "National Hospital Organization Kinki-Chuo Chest Medical Center" are "Drug" (37 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Carboplatin" (6 trials), "Nintedanib" (6 trials), "Pemetrexed" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

Clinical Trials Genders at National Hospital Organization Kinki-Chuo Chest Medical Center


The vast majority of trials in "National Hospital Organization Kinki-Chuo Chest Medical Center" are 40 trials for "All" genders.

Clinical Trials Status at National Hospital Organization Kinki-Chuo Chest Medical Center


Currently, there are NaN active trials in "National Hospital Organization Kinki-Chuo Chest Medical Center". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in National Hospital Organization Kinki-Chuo Chest Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Kinki-Chuo Chest Medical Center, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 28Phase 3: 28Phase 2: 4Phase 2: 4Phase 4: 3Phase 4: 3Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 22Completed: 22Recruiting: 8Recruiting: 8Active, not recruiting: 6Active, not recruiting: 6Terminated: 4Terminated: 4